[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100564536":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":40,"responsibleParty":55,"collaborators":26,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":26,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":26,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":26,"overallStatus":42,"whyStopped":26,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Pusan National University Yangsan Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Meu-cinn group","EXPERIMENTAL","This group takes Meu-cinn for 8 weeks.",[13],"Dietary Supplement: Meu-cinn",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo group","PLACEBO_COMPARATOR","This group takes placebo for 8 weeks.",[19],"Dietary Supplement: Placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Meu-cinn","Meu-cinn 250 mg\u002Fday for 8 weeks",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Placebo","Placebo 250 mg\u002Fday for 8 weeks",[15],[32],{"name":33,"affiliation":5,"role":34},"Sang Yeoup Lee, Professor, MD, PhD","PRINCIPAL_INVESTIGATOR",[36],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","82+55-360-2860","drsaylee@gmail.com",[41],{"facility":5,"status":42,"city":43,"state":26,"zip":44,"country":45,"countryCode":26,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"RECRUITING","Yangsan","50612","South Korea",{"type":47,"coordinates":48},"Point",[49,50],129.03358,35.34199,{"lat":50,"lon":49},[53],{"name":33,"role":37,"phone":54,"phoneExt":26,"email":39},"82-55-360-2860",{"type":34,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Sang Yeoup Lee","Professor","100564536","meu-cinn-for-gastric-mucosal-health-in-adults-with-functional-dyspepsia-100564536",false,"NCT06630455","Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia","Effects of Meu-cinn on Promoting Gastric Mucosal Health in Adults With Functional Dyspepsia: A Randomized, Double-blind, Placebo-controlled Clinical Trial","Inclusion Criteria:\n\n* Rome IV-based functional dyspepsia-\n\nExclusion Criteria:\n\n* Patients with gastrointestinal symptoms requiring immediate drug treatment.\n* Individuals with a history of hypersecretory gastric disorders like Zollinger-Ellison syndrome.\n* Individuals who received Helicobacter pylori eradication therapy within 4 weeks prior to the trial.\n* Individuals who have taken nonsteroidal anti-inflammatory drugs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within the last month.\n* Individuals with a history of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection within the last year.\n* Individuals with gastric ulcers (active or healing), duodenal ulcers (active or healing), reflux esophagitis (LA grade A or higher), or malignant tumors identified within the last 6 months through endoscopy.\n* Patients with uncontrolled hypertension (resting BP ≥160\u002F100 mmHg).\n* Patients with uncontrolled diabetes (fasting glucose ≥160 mg\u002FdL).\n* Individuals with creatinine levels ≥ 2 times the upper limit of normal at the research institution.\n* Individuals with aspartate aminotransferase or alanine aminotransferase levels ≥ 2 times the upper limit of normal at the research institution.\n* Alcohol abusers.\n* Individuals taking medications for psychiatric disorders (except those taking intermittent medication for sleep disorders).\n* Pregnant or breastfeeding women or those planning to become pregnant during the clinical trial period.\n* Individuals with allergies to any components of the study foods.\n* Individuals who participated in or plan to participate in another drug clinical trial within the last month.\n* Individuals deemed unsuitable for the study by the investigator for other reasons.",true,"ALL","19 Years","70 Years",{"count":70,"type":71},100,"ESTIMATED","INTERVENTIONAL",[74],"NA","This clinical trial aims to determine whether Meu-cinn promotes gastric mucosal health in adults with functional dyspepsia and to assess its safety.\n\nThe main questions are:\n\n* Does Meu-cinn promote gastric mucosal health in participants?\n* What side effects occur when participants take Meu-cinn?",[77],"Functioanl Dyspepsia","2025-06-01",{"date":80,"type":81},"2025-06-03","ACTUAL",{"date":83,"type":81},"2024-12-04",{"date":85,"type":71},"2025-12-31",{"name":5,"class":6},1]